Best of the Blog is a monthly column highlighting the best of our free online content at www.windhover.com/blog. In April, Windhover’s editorial staff posted 44 articles to the site, covering biopharma, device and diagnostics R&D, business development, regulatory, and commercial news. Last month we digested FDA’s decisions against Cordaptive and Singulair/Claratin alongside our ongoing real-time deal analysis. Here are a few of our favorite blog posts for stories not covered elsewhere in this month’s IN VIVO.
In an article in [last] month's IN VIVO, we suggested that Merck & Co. Inc.’s presenting Cordaptive to FDA...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?